Compared to the test cohort, HIV-positive subjects in the validation cohort had lower median CD4 T cell counts, CD4 nadir, CD4:CD8 ratio, and longer median duration of HIV infection, indicating more advanced HIV disease. The gene discussed is CD8A; the disease is HIV infectious disease.